Anavex Life Sciences Corp (AVXL)

[nidan7500]

Congratulations to AVXL staff for this new Patent...it is all stacked overhead and will be cleared to land.

Anavex Life Sciences Corp.
Wed, November 22, 2023 at 8:00 AM EST
In this article:

AVXL
-4.00%
Watchlist

Watchlist
Patternyahoo plus badge
Neutral
trade type U
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
Grant of Its Newest U.S. Patent Expands Anavex’s Compounds Intellectual Property Portfolio

NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that the United States Patent and Trademark Office (USPTO) granted U.S. Patent No. 11,813,242 entitled “A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION”. This patent expands Anavex’s existing patent coverage of ANAVEX®2-73 (blarcamesine), including U.S. Patent No. 11,337,953 to cover Anavex’s leading drug candidate, ANAVEX®2-73 (blarcamesine), ANAVEX®1-41 and ANAVEX®19-144, for treating insomnia, anxiety or agitation.